自体血清及其成分治疗干眼症的研究进展
干眼症是一种多因素眼表疾病,自体血清滴眼液自1975年首次报告以来被广泛用于治疗干眼,但其制备方法和临床应用尚未标准化,疗效仍不明确,需设计良好、大规模、高质量的随机对照试验以标准化治疗和使用来阐明疗效。血清成分与泪液成分部分相似,自体血清滴眼液通过提供生长因子、蛋白质和维生素等泪液成分改善干眼。此外,在干眼大鼠模型中,硒蛋白P(SeP)滴眼液较磷酸盐缓冲液显著降低角膜荧光素评分并抑制角膜氧化应激,改善角膜病变,提示SeP为新的治疗候选分子。
要点
- 自体血清滴眼液广泛用于干眼,但制备与临床应用未标准化,疗效尚不明确。
- 需大规模高质量随机对照试验以标准化治疗和使用来阐明自体血清疗效。
- 硒蛋白P滴眼液在干眼大鼠模型中降低角膜荧光素评分并抑制氧化应激。
核心结论
- 自体血清滴眼液治疗干眼的疗效因制备方法和临床应用未标准化而仍不明确,需标准化治疗和使用的大规模高质量随机对照试验阐明。
- 硒蛋白P滴眼液在干眼大鼠模型中较磷酸盐缓冲液显著降低角膜荧光素评分并抑制角膜氧化应激,改善角膜病变。
研究设计与样本
- 系统研究结果显示自体血清滴眼液疗效不明确,因制备方法和临床应用未标准化。
- 将硒蛋白P滴眼液应用于干眼大鼠模型以评估其治疗干眼的效果。
- 开发了由氧化应激引起的新型干眼模型,用于筛选具有抗氧化活性的候选分子。
主要发现
- 自体血清滴眼液自1975年首次报告以来被专家广泛使用。
- 血清成分与泪液成分部分相似,自体血清滴眼液通过提供生长因子、蛋白质和维生素等泪液成分改善干眼。
- 与磷酸盐缓冲液治疗相比,硒蛋白P滴眼液显著降低角膜荧光素评分并抑制角膜氧化应激,改善角膜病变。
临床怎么用
- 自体血清滴眼液可用于干眼治疗,但需注意其制备方法和临床应用尚未标准化。
- 硒蛋白P作为血清中新发现的候选分子,在干眼大鼠模型中显示治疗潜力,尚需进一步临床研究验证。
局限性
- 自体血清滴眼液的制备方法和临床应用尚未标准化,导致疗效不明确。
- 硒蛋白P的治疗效果仅在干眼大鼠模型中揭示,尚未在人体研究中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dry eye syndrome is a multifactorial condition on the tear and ocular surface. Autologous serum eye drop is an effective method for treating dry eye. Autologous serum eye drops are now widely used by specialists since a first report in 1975. The results of a systematic study showed that the efficacy of autologous serum eye drops remains ambiguous because its preparation methods and clinical application have not been standardized. To elucidate the efficacy of autologous serum eye drops, well-designed, large-scale, high-quality randomized controlled trials need to be conducted with standardized treatment and use. Since serum components are partially similar to tear components, autologous serum eye drops improve dry eye by supplying tear components such as growth factors, proteins, and vitamins. Adding to the evidence based on the treatment of dry eye, we have found a new treatment candidate from serum: selenoprotein P (SeP). The efficacy of SeP as a treatment for dry eye was revealed by applying SeP eye drops to a dry eye rat model. Compared with phosphate-buffered saline treatment, SeP eye drops significantly reduced the fluorescein score of the cornea and suppressed the oxidative stress in the cornea, which is related to onset of dry eye, leading to improved corneal disorder. We have developed a new dry eye model caused by oxidative stress that will be used to screen candidate molecules for antioxidative activity.
引用
- Higuchi A. Autologous Serum and Serum Components. Invest Ophthalmol Vis Sci. 2018. PMID: 30481816. doi:10.1167/iovs.17-23760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。